A double-blind, multicentric, multinational randomised study to assess the effects of one year administration of 2 g per day of strontium ranelate versus marketed bisphosphonates in women with postmenopausal osteoporosis on bone microarchitecture as measured by high-resolution peripheral-quantitative computed tomography (p-QCT)
Not Applicable
Completed
- Conditions
- Post-menopausal osteoporosisMusculoskeletal Diseases
- Registration Number
- ISRCTN82719233
- Lead Sponsor
- Institut de Recherches Internationales Servier (France)
- Brief Summary
2010 results in: http://www.ncbi.nlm.nih.gov/pubmed/20512336
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 72
Inclusion Criteria
1. Women of at least 50 years old
2. Postmenopausal for at least five years
3. Osteoporosis
Exclusion Criteria
1. Body mass index (BMI) <18 or >30 kg/m^2
2. Skeletal disease
3. Severe malabsorption
4. Significant and evolutive hyperthyroidism
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method